Why the study?
Platelets may play a key role in arterial thromboembolic disease in cancer patients, making the investigation of platelet aggregation in lung cancer patients undergoing different surgical approaches important.
Does VATS lobectomy compared to thoracotomy affect platelet aggregation in patients with primary lung cancer?
Does VATS lobectomy compared to thoracotomy affect platelet aggregation in patients with primary lung cancer?
Patients with primary lung cancer have significantly increased baseline platelet aggregation compared to healthy individuals, which further increases on the first postoperative day regardless of surgical approach.
Answers are grounded in this paper and cite their sources.
May signal heightened perioperative thrombotic risk in lung cancer; leaves open whether surgical approach modulates aggregation.
A growing interest concerns arterial thromboembolic disease in cancer patients. As platelets may be key players in this process, investigation of platelet aggregation in cancer patients is of importance. We aimed to investigate platelet aggregation in patients with lung cancer prior to surgery and during video-assisted thoracoscopic surgery (VATS) lobectomy compared with lobectomy performed through a thoracotomy. We included 93 patients (VATS + low molecular weight heparin (LMWH), n = 32; VATS no LMWH, n = 31; thoracotomy + LMWH, n = 30). Data obtained from 121 healthy individuals were used for comparison prior to surgery. Platelet aggregation was analysed by impedance aggregometry using adenosine diphosphate 6.5 μM (ADPtest) and collagen 3.2 μg/mL (COLtest) as agonists. Prior to surgery, platelet aggregation was significantly increased in both VATS-patients (ADPtest, p < .0001; COLtest, p = .0002) and patients undergoing thoracotomy (ADPtest, p < .0001; COLtest, p < .0001) compared with healthy individuals. Platelet aggregation did not differ between VATS-patients and thoracotomy patients prior to surgery (p-values >.11). At the first postoperative day, VATS-patients demonstrated significantly higher collagen-induced platelet aggregation than preoperatively (p = .001), but the increase in platelet aggregation did not differ significantly between VATS and thoracotomy patients (p-values ≥.24). At the second postoperative day, platelet aggregation was significantly reduced in thoracotomy patients compared with the preoperative level (ADPtest, p = .002; COLtest, p = .05). In conclusion, platelet aggregation was significantly increased in patients with primary lung cancer prior to surgery compared with healthy individuals. At the first postoperative day, platelet aggregation was significantly higher than the preoperative level in VATS-patients; however, this increase did not differ between patient groups.
No takes yet. Share an insight, caveat, or question.
Hvas et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: